Seeking Alpha

OncoGenex Pharmaceuticals (OGXI +1.4%) trades up today after saying it's initiating Phase 2...

OncoGenex Pharmaceuticals (OGXI +1.4%) trades up today after saying it's initiating Phase 2 clinical studies to evalutate OGX-427, a treatment for patients with advanced metastatic bladder cancer. The study is sponsored by Hoosier Oncology Group.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs